Navigation Links
Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Date:3/3/2008

harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercial
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Consortium publishes Phase II map of human genetic variation
11. The Lancet Publishes Vasogens ACCLAIM Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...arch report is available in its catalogue: ,, ...: Market dynamics and the changing healthcare and ...nker.com/p0165658/Emerging-Clinical-Trial-Location...g-healthcare-and-regulatory-environment.html ,...
(Date:12/1/2009)..., , SHANGHAI, Dec. 1 /PRNewswire-Asia...ary of ShangPharma, a leading China-based Contract...s a winner of the 2009 Deloitte,Technology Fast 50...wing high,tech companies in China. The award is a ...revenue growth from 2006 to 2008. , The r...
(Date:12/1/2009)... Enterprise level storage... care providers without breaking the bank. , ...csDrive, LLC. ( www.pacsdrive.com ), a medical i...a new DICOM compatible cloud storage service. The ...ealth care providers to securely archive medical i...
(Date:12/1/2009)..., , SAN DIEGO, Dec. 1 /PRNewswire... Board: AEMD) announced today that it will present...3, 2009 at 2:00 p.m. (PST) at the Luxe Hotel in Lo...es A. Joyce, will present a corporate overview and...progress for its lead product, the Hemopurifier...
Breaking Biology Technology:Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2
...today,received information from Danske Bank, that ...ivsforsikring and Danske Fund FCP - through,acquis...hares of a nominal,value of each DKK 1 correspondi...voting rights in Exiqon A/S., About Exiqon, Exiq...scientific,expertise in gene expression with our p...
...ications bear more than a passing resemblance to d...erally to capture all the colors of the spectrum, ...t from across the spectrum moves through optical c...rcuits contain dimensions measured in nanometers. ...andidate in electrical engineering at Lehigh Unive...
...WYE ) has,announced that Bernard Poussot, 56, Wyet...umed the additional position of Chairman of the Bo...t to a previously announced election by the,Compan...a succession plan,that began in April 2006 when Mr...man. In January 2007, he was named President and C...
Other Biology Technology:Using a grating with a grade, engineers trap a rainbow 2Using a grating with a grade, engineers trap a rainbow 3
(Date:12/1/2009)... United States, the other from Canada, put the sat...ck, on remote Ellesmere Island, only 600 miles fro...what these "North Pole wolves" do in the long, dar...he world., "We first encountered 9-year-old Brut... Geological Survey (USGS) wolf researcher who has ...
(Date:12/1/2009)...wire/ -- iQor, a global provider of business proce... 2009 InfoWorld 100 Awards Top 100 IT project of... This was the first submission for iQor. ,, "We...us list of companies," said Vikas Kapoor, presiden...ng the way we do business, allowing us to work fas...
(Date:12/1/2009)...ideo of individual breast tissue cells reveals a n...otein that cycles between two major compartments i...mplete view of the internal signals that cause bre...ancer and are targets of drug development. , Th... factors, travels back and forth between the nucle...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2UT Southwestern physicians bust myths about insulin 54134 1UT Southwestern physicians bust myths about insulin 54134 2Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 1Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 2
...t seems size does matters after all. But for flyin...ty of Chicago researchers. , In the May 15, 2005,...entists described the effects of size and behavior...als were better gliders. , "Despite their lack of ...rial locomotors," said lead scientist and author J...
...ohns Hopkins infectious disease specialists who ha...combat HIV and AIDS worldwide are warning that lim...al therapies currently being distributed in Africa... can least afford to pay for them. , In an article...h online June 28, infectious disease specialist Jo...
...n early type of antibiotic-resistant bacteria that...0s has re-emerged as one of the community-acquired...in The Lancet tomorrow (Saturday 2 April 2005). , ...at caused a pandemic 40-50 years ago could mean th...be more widespread than previously expected, warns...
Other Biology News:Researchers reveal secrets of flying snakes 2Researchers reveal secrets of flying snakes 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4Community MRSA is re-emergence of 1950s pandemic, study suggests 2
Acridine orange, hemizinc salt from Research Organics, Inc.
Auto/Zyme Reagent Set from Biomeda Corporation
DAPI from Research Organics, Inc.
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Biology Products: